Literature DB >> 16192888

Congenital melanosis: an update.

Dominic F Heffel1, Seth Thaller.   

Abstract

Congenital nevi remain a constant and challenging clinical entity for plastic surgeons due to the unsettled question regarding the true incidence of conversion to melanoma. This paper will review the recent distinction described in the literature. To truly obtain a current authoritative accord, a new interdisciplinary consensus conference should probably be convened to review and initiate new standards regarding available treatment modalities and their indications.

Entities:  

Mesh:

Year:  2005        PMID: 16192888     DOI: 10.1097/01.scs.0000179751.29284.51

Source DB:  PubMed          Journal:  J Craniofac Surg        ISSN: 1049-2275            Impact factor:   1.046


  5 in total

1.  Neurocutaneous melanocytosis (melanosis).

Authors:  Martino Ruggieri; Agata Polizzi; Stefano Catanzaro; Manuela Lo Bianco; Andrea D Praticò; Concezio Di Rocco
Journal:  Childs Nerv Syst       Date:  2020-10-13       Impact factor: 1.475

Review 2.  Oral Congenital Melanocytic Nevus: A Rare Case Report and Review of the Literature.

Authors:  Helvécio Marangon Júnior; Paulo Eduardo Alencar Souza; Rodrigo Villamarim Soares; Bruno Augusto Benevenuto de Andrade; Oslei Paes de Almeida; Martinho Campolina Rebello Horta
Journal:  Head Neck Pathol       Date:  2015-07-05

3.  [Therapy of congenital melanocytic nevi. Excision, dermabrasion, laser].

Authors:  B Konz
Journal:  Hautarzt       Date:  2007-08       Impact factor: 0.751

4.  An unusual case of congenital melanocytic nevus presenting as neurocutaneous melanoma coexisting with Tuberous Sclerosis complex: A case report.

Authors:  Santosh Rai; Piyush Kalakoti; Mm Aarif Syed; Purujit J Thacker; Rishi Jain; Gaurav Kalra
Journal:  J Med Case Rep       Date:  2011-07-01

5.  Neurocutaneous melanosis presenting as chronic partial epilepsy.

Authors:  Byoung Seok Ye; Yang-Je Cho; Sang Hyun Jang; Byung In Lee; Kyoung Heo; Hyun Ho Jung; Jin Woo Chang; Se Hoon Kim
Journal:  J Clin Neurol       Date:  2008-09-30       Impact factor: 3.077

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.